Biotechnology Stocks I Performance Guide: Regeneron Pharmaceuticals, Inc. (REGN)
REGN has no dividends.
Table and Chart of REGN Performance
See what a $1,000 investment in REGN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| REGN Returns | |
|---|---|
| Start Date | Oct-31-2014 |
| Start Price | $393.72 |
| End Date | Oct-04-2024 |
| End Price | $1,012.82 |
| # Prices | 121 |
| Min Date | Sep-30-2019 |
| Min Price | $277.40 |
| Max Date | Aug-30-2024 |
| Max Price | $1,184.69 |
| Total Return | 157.24% |
| Annualized Return | 9.82% |
| Current Value of $1,000 Purchase | $2,572 |
| Number Returns | 7,260 |
| Average Return | 46.01% |
| Number Profitable Returns | 5,530 |
| Percent Profitable Returns | 76.17% |
| Number Unprofitable Returns | 1,730 |
| Percent Unprofitable Returns | 23.83% |
| Profitable to Unprofitable Returns Ratio | 3.20 |
| REGN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | 20.470 | Price to Sales | 20.75 |
| Earnings per Share | $0.0000 |
| PE Ratio | 4519100000 |
| PE to Growth Ratio | 26.81 |
| Price to Book | 8.28 |
| PRICE DATA | |
| 52 Week High | $0.115 |
| 52 Week Low | $1211.2 |
| Analyst Target Price | $0.123 |
| 50-Day Moving Average | $769.19 |
| 200-Day Moving Average | $1123.53 |
| FINANCIAL DATA | |
| Revenue per Share | $37.78 |
| Revenue | $0 |
| Profit Margin | 12583% |
| Return on Equity | 7.62% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
REGN Compare Returns with S&P 500
REGN Trendline Chart
REGN Moving Average Chart
REGN Stock Return Map - See Patterns of Gains and Losses
REGN Stock Returns/Purchase Dates